Provided by Tiger Trade Technology Pte. Ltd.

First Trust NYSE Arca Biotechnology Index Fund

272.38
+3.421.27%
Post-market: 272.380.00000.00%16:15 EDT
Volume:66.21K
Turnover:18.03M
Market Cap:2.96B
PE:31.87
High:272.91
Open:270.25
Low:270.25
Close:268.96
52wk High:272.91
52wk Low:171.06
Shares:10.85M
Float Shares:10.85M
Volume Ratio:0.89
T/O Rate:0.61%
Dividend:- -
Dividend Rate:- -
EPS(TTM):8.55
EPS(LYR):37.75
ROE:19.96%
ROA:-0.16%
PB:2.23
PE(LYR):7.21

Loading ...

Bruker Q2 Gross Profit USD 416 Million

THOMSON REUTERS
·
Aug 04

Alkermes EVP, CLO David Joseph Gaffin Sells 2,034 Shares for $98,821.72

Reuters
·
Aug 04

Veracyte is Maintained at Hold by Canaccord Genuity

Dow Jones
·
Aug 04

Corcept CFO Atabak Mokari Sells 79,000 Shares Worth $8.95 Million

Reuters
·
Aug 04

ClearPoint Neuro reports Q2 EPS (38c), consensus (29c)

TIPRANKS
·
Aug 04

Top News Today/Canada: WestJet Strike Grounds Hundreds of Flights in Canada

Dow Jones
·
Aug 04

Alkermes Amends 8-K to Disclose CEO Blair Jackson Pay Package Including $5 Million Equity Award

Reuters
·
Aug 04

3 High Growth Stocks Investors May Be Missing Right Now

Simply Wall St.
·
Aug 03

Coursera Stock And 2 More Growth Picks Backed By Healthy Balance Sheets

Simply Wall St.
·
Aug 02

OTLK, HBAN, CORT, CAPR, GOSS Trending With Analysts

TIPRANKS
·
Aug 01

LIVE Markets-us Earnings Forecast Jumps Further After Key Reports This Week

Reuters
·
Aug 01

Veracyte falls -24.0%

TIPRANKS
·
Jul 31

Workday Stock And 2 Software Picks Backed By Insider Confidence

Simply Wall St.
·
Jul 31

Veracyte Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 31

Veracyte Q2 FY26 Swings to GAAP Net Income of $25.5 Million; Revenue Rises 15% to $150.3 Million

Reuters
·
Jul 31

Veracyte Q2 Revenue Rises on Decipher and Afirma Test Sales

Reuters
·
Jul 31

Fulgent Genetics Q2 Revenue Rises 20% Sequentially, Sees Billing System Transition Delay

Reuters
·
Jul 31

CareDx Q2 Revenue Beats Estimates; Outlook Lifted

Reuters
·
Jul 31

Veracyte Q2 Revenue USD 150.3 Million Vs. IBES Estimate USD 144.6 Million

Reuters
·
Jul 31

Veracyte Outlook 2026 - Continues to Expect Adjusted Ebitda Margin to be Greater than 26%

THOMSON REUTERS
·
Jul 31